Wells Fargo & Company Mustang Bio, Inc. Transaction History

Wells Fargo & Company

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.35 - $0.72 $4 - $10	14 Added 0.68%	2,086 $0
Q4 2022 Feb 13, 2023	BUY	$0.32 - $0.52 $9 - $16	31 Added 1.52%	2,072 $0
Q3 2022 Nov 14, 2022	SELL	$0.46 - $0.76 $6,442 - $10,644	-14,006 Reduced 87.28%	2,041 $1,000
Q2 2022 Aug 12, 2022	BUY	$0.58 - $1.13 $452 - $881	780 Added 5.11%	16,047 $9,000
Q1 2022 May 16, 2022	SELL	$0.73 - $1.81 $18,676 - $46,307	-25,584 Reduced 62.63%	15,267 $16,000

Q4 2021 Feb 14, 2022	BUY	$1.66 - $2.64 $27,142 - $43,166	16,351 Added 66.74%	40,851 $68,000
Q3 2021 Nov 15, 2021	BUY	$2.58 - $3.36 $15,678 - $20,418	6,077 Added 32.99%	24,500 $66,000
Q2 2021 Aug 16, 2021	SELL	$2.7 - $3.81 $30,647 - $43,247	-11,351 Reduced 38.12%	18,423 $61,000
Q1 2021 May 13, 2021	SELL	$3.02 - $5.16 $176,878 - $302,216	-58,569 Reduced 66.3%	29,774 $99,000
Q4 2020 Feb 09, 2021	BUY	$2.66 - $4.18 $148,183 - $232,859	55,708 Added 170.7%	88,343 $335,000
Q3 2020 Nov 05, 2020	SELL	$3.01 - $3.88 $30,364 - $39,141	-10,088 Reduced 23.61%	32,635 $103,000
Q2 2020 Aug 13, 2020	BUY	$2.33 - $4.6 $18,134 - $35,801	7,783 Added 22.28%	42,723 $136,000
Q1 2020 May 14, 2020	BUY	$1.91 - $4.52 $66,735 - $157,928	34,940 New	34,940 $94,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $46.3M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.